GoodRx Holdings, Inc. 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds Unregistered Sales of Equity Securities None. Use of Proceeds On September 25, 2020, we completed our IPO. All shares sold were registered pursuant to a registration statement on Form S-1 (File No. 333-248465), as amended (the “Registration Statement”), declared effective by the SEC on September 22, 2020. As of March 31, 2026 , the $886.9 million net proceeds from our IPO have been fully utilized for the purposes described in our Registration Statement: (i) $197.9 million for the acquisition of businesses that complement our business; (ii) $448.2 million for the repurchases of our Class A common stock; (iii) $160.0 million for the repayment of our outstanding debt obligations; and (iv) $80.8 million for working capital and other general corporate purposes. Issuer Repurchases of Equity Securities The following table presents information with respect to our repurchases of our Class A common stock during the three months ended March 31, 2026 . Period Total Number of Shares Repurchased (1) Average Price Paid per Share (2) Total Number of Shares Repurchased as Part of Publicly Announced Program (1) Approximate Dollar Value of Shares that May Yet Be Repurchased Under the Program (in thousands) January 1 - 31 — $ — — $ — February 1 - 28 — $ — — $ — March 1 - 31 5,535,548 $ 2.28 5,535,548 $ 60,218 Total 5,535,548 5,535,548 _____________________________________________________ (1) The repurchases are being executed from time to time, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, which may include repurchases through a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)(1) under the Exchange Act. See Note 9 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information related to our $450.0 million stock repurchase program with no expiration date, which was publicly announced on February 29, 2024. (2) Average price paid per share includes direct costs and estimated excise taxes associated with the repurchases. Item 3. Defaults Upon Senior Securities None. Item 4. Mine Safety Disclosures Not applicable.